Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 143.00
Bid: 143.00
Ask: 143.60
Change: 2.00 (1.42%)
Spread: 0.60 (0.42%)
Open: 140.00
High: 145.00
Low: 140.00
Prev. Close: 141.00
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 update

19 Mar 2020 07:00

ELEMENTIS PLC - COVID-19 update

ELEMENTIS PLC - COVID-19 update

PR Newswire

London, March 18

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Elementis plc

COVID-19 update

Suspension of the 2019 final dividend and relaxation of banking covenants

Elementis plc (“Elementis” or the “Group”), a global specialty chemicals company, today provides an update on the impact of the COVID-19 pandemic on its business and a change to its banking covenants.

Business performance

Up to 18 March 2020, the Group has experienced a solid start to the year with limited impact on production and demand from COVID-19. Our sites around the world remain open and are operating at normal levels. Trading and performance has been in line with our expectations, benefitting from efficiency actions implemented in 2019, with overall progress in Personal Care, Coatings and Talc. Market conditions are unchanged in Chromium.

The impact of COVID-19 however presents significant demand and operating uncertainty. Our immediate priorities remain safeguarding the health and wellbeing of our employees, and supporting our customers.

The Group is also taking steps to mitigate any potential material adverse financial impact, with focus on optimisation of cash flow via cost savings, working capital reduction and tight management of capex.

Liquidity, banking covenants and dividend

The Group has very ample liquidity, with in total over $300m immediately available. Total net debt for the Group, excluding lease liabilities under IFRS 16, was $454m at 31 December 2019, representing a ratio of 2.7x EBITDA*.

Elementis is a highly cash generative business, with average operating cash conversion of over 90% over the last 3 years. However, given market and economic uncertainties, the Group has taken two steps to provide additional financial headroom and preserve cash.

First, Elementis has secured a relaxation of its banking covenants from 3.25x to 3.75x net debt/EBITDA*. This will apply for two testing periods (i.e. 30 June 2020 and 31 December 2020).

Second, the Board has decided that given the uncertainties at this time it is prudent to preserve cash. Therefore, the 2019 final dividend of 4.4487 pence per share will no longer be proposed at the AGM scheduled for 29 April 2020. The cash impact of this decision to suspend the dividend is $33m in H1 2020. Future dividend decisions will be made as and when conditions normalise.

Paul Waterman, CEO of Elementis said:

“While our business performance to-date is in line with our expectations, we are acutely aware of the increased level of market and macroeconomic uncertainty. Our focus remains on what we can control, namely active cost and cash management. The relaxation of our banking covenants and the decision to suspend the final dividend will create material additional financial headroom to counter the potential impacts of the global COVID-19 crisis.”

Enquiries

Elementis plcJames Curran, Investor Relations Tel: 020 7067 2994

Tulchan Martin Robinson Tel: 020 7353 4200David Allchurch

Note: *Pre IFRS 16

Date   Source Headline
21st Apr 20112:40 pmRNSResult of AGM
21st Apr 20117:00 amRNSAGM / Interim Management Statement
5th Apr 20119:00 amRNSDirector/PDMR Shareholding
25th Mar 201112:00 pmRNSTotal Voting Rights
25th Mar 201111:00 amRNSAnnual Information Update
22nd Mar 20112:08 pmRNSAnnual Financial Report and Notice of 2011 AGM
21st Mar 20113:23 pmRNSDirector/PDMR Shareholding
21st Mar 20113:02 pmRNSDirector/PDMR Shareholding
1st Mar 20117:00 amRNSFinal Results
14th Feb 20113:05 pmRNSChange to director's details
4th Feb 201111:00 amRNSChange to director's details
10th Nov 20103:35 pmRNSHolding(s) in Company
5th Nov 20102:20 pmRNSDirector/PDMR Shareholding
5th Nov 20102:17 pmRNSDirector/PDMR Shareholding
1st Nov 20107:00 amRNSInterim Management Statement
29th Oct 20102:02 pmRNSTotal Voting Rights
2nd Aug 20107:00 amRNSHalf Yearly Report
28th May 201012:00 pmRNSTotal Voting Rights
24th May 20107:00 amRNSTrading Statement
20th May 20109:00 amRNSDirector/PDMR Shareholding
26th Apr 20109:00 amRNSChange of presentation currency
22nd Apr 20107:00 amRNSInterim Management Statement
23rd Feb 20107:00 amRNSPreliminary Results
21st Jan 20104:35 pmRNSPrice Monitoring Extension
31st Dec 20091:25 pmRNSTotal Voting Rights
21st Dec 200911:31 amRNSHolding(s) in Company
9th Oct 200910:17 amRNSSchroders TR1
7th Oct 20099:10 amRNSHolding(s) in Company
3rd Aug 20097:00 amRNSInterim Results 2009
24th Feb 20097:00 amRNSPreliminary results
22nd Dec 20084:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20084:38 pmRNSPrice Monitoring Extension
8th Dec 20084:40 pmRNSSecond Price Monitoring Extn
8th Dec 20084:35 pmRNSPrice Monitoring Extension
21st Nov 20084:50 pmRNSSecond Price Monitoring Extn
21st Nov 20084:36 pmRNSPrice Monitoring Extension
10th Oct 20084:50 pmRNSSecond Price Monitoring Extn
10th Oct 20084:37 pmRNSPrice Monitoring Extension
18th Aug 200811:04 amRNSHolding(s) in Company
1st Aug 200812:10 pmRNSBlocklisting Interim Review
31st Jul 20083:00 pmRNSTotal Voting Rights
28th Jul 20087:00 amRNSInterim Results
8th Jul 200810:54 amRNSAppointment of non-executive
3rd Jul 20088:41 amRNSDate of interim results annou
1st Jul 20089:53 amRNSCompletion of Deuchem acquisi
30th Jun 20082:04 pmRNSTotal Voting Rights
30th Jun 20081:35 pmRNSAdditional Listing
26th Jun 20083:37 pmRNSDirector/PDMR Shareholding
26th Jun 20087:00 amRNSTrading Statement
30th May 20084:54 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.